BRIEF

​

India's healthcare, pharma, life sciences, and medical devices industries are undergoing rapid transformation, spurred by innovation, regulatory change, digital disruption, and increasing global scrutiny. In this high-stakes environment, General Counsels (GCs) are playing a pivotal role, not just as risk managers, but as strategic advisors navigating the intersection of law, ethics, compliance, innovation, and business continuity.

​

This conference is designed specifically for GCs and senior legal leaders from across the healthcare spectrum, covering pharmaceuticals, biotechnology, life sciences R&D, hospital networks, medtech manufacturing, diagnostics, and digital health platforms. The goal is to foster practical dialogue on the evolving regulatory environment, corporate governance, cross-border risk, IP strategy, internal investigations, ESG mandates, and emerging technologies.

​

OBJECTIVES

​​​​

• Provide a platform for peer-to-peer learning among legal leaders in the healthcare space

• Discuss high-impact regulatory and compliance trends affecting the industry

• Address challenges in internal investigations, whistleblower protection, and ethics management

• Share insights into strategic IP protection and licensing in a globalised R&D context

• Understand the GC’s evolving role in cross-border operations, ESG, and risk leadership

​

TARGET AUDIENCE

​

• General Counsels & Heads of Legal

• Senior Legal Counsels, Chief Compliance Officers

• Regulatory Affairs Heads

• Chief Compliance Officers

• Company Secretary

• Chief Financial Officers​

​

AGENDA (tenative - to be finalised)

​

• Recalibrating Risk: Role of GC in the Healthcare Boardroom

• Ethics, Whistleblowing & Internal Investigations: Raising the Bar

• M&A in Healthcare: Navigating Regulatory & Cultural Integration

• AI, Digital Health & Data Privacy: What Should GCs Be Watching?

• Anti-bribery and Anti-corruption Risks in Pharma Marketing and Clinical Research

• Advertising, Labeling and Marketing of Drugs & Medical Devices

• Managing Legal Risks in Cross-Border Supply Chains

• Best Practices for Joint Ventures and Collaborations in R&D and Manufacturing

• Sustainable Manufacturing and Green Compliance in Pharma and MedTech

​